John A. Morrow

2.7k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

John A. Morrow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, John A. Morrow has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in John A. Morrow's work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (8 papers) and Neuropeptides and Animal Physiology (6 papers). John A. Morrow is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (8 papers) and Neuropeptides and Animal Physiology (6 papers). John A. Morrow collaborates with scholars based in United Kingdom, United States and France. John A. Morrow's co-authors include Anthony J. Harmar, E.M. Lutz, West Km, George Fink, W. John Sheward, Matthew Fell, Genta Ito, Matthias Trost, Francesca Tonelli and Paul Davies and has published in prestigious journals such as Brain Research, FEBS Letters and Annals of the New York Academy of Sciences.

In The Last Decade

John A. Morrow

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

2016 705 citations Matthew Fell, John A. Morrow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Morrow United Kingdom	15	903	891	658	355	345	21	1.8k
Nadia Canu Italy	28	982 1.1×	732 0.8×	228 0.3×	314 0.9×	882 2.6×	43	2.0k
Véronique Sazdovitch France	19	784 0.9×	375 0.4×	395 0.6×	142 0.4×	454 1.3×	34	1.9k
Rakel López de Maturana United Kingdom	19	612 0.7×	447 0.5×	221 0.3×	69 0.2×	389 1.1×	23	1.2k
Lone Helboe Denmark	26	637 0.7×	493 0.6×	293 0.4×	51 0.1×	309 0.9×	42	1.7k
Juan M. Luque Spain	22	557 0.6×	727 0.8×	132 0.2×	87 0.2×	228 0.7×	41	1.6k
Maureen W. McEnery United States	25	2.1k 2.3×	1.5k 1.6×	147 0.2×	137 0.4×	289 0.8×	38	2.8k
E. Miyamoto Japan	23	1.1k 1.2×	765 0.9×	81 0.1×	328 0.9×	237 0.7×	45	1.7k
A. Faivre‐Bauman France	24	607 0.7×	743 0.8×	41 0.1×	158 0.4×	192 0.6×	63	1.5k
Pascal Kienlen‐Campard Belgium	27	1.3k 1.5×	503 0.6×	143 0.2×	231 0.7×	1.4k 4.2×	68	2.3k
Xiao-Jiang Li United States	10	1.4k 1.6×	1.3k 1.5×	477 0.7×	165 0.5×	282 0.8×	15	2.0k

Countries citing papers authored by John A. Morrow

Since Specialization

Citations

This map shows the geographic impact of John A. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Morrow more than expected).

Fields of papers citing papers by John A. Morrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Morrow. The network helps show where John A. Morrow may publish in the future.

Co-authorship network of co-authors of John A. Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Morrow. A scholar is included among the top collaborators of John A. Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Morrow. John A. Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grauer, Steven M., Raul Sanoja, Dominic Poulin, et al.. (2020). Antinociceptive effects of potent, selective and brain penetrant muscarinic M4 positive allosteric modulators in rodent pain models. Brain Research. 1737. 146814–146814. 2 indexed citations

Fell, Matthew, Christian Mirescu, Kallol Basu, et al.. (2015). MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. Journal of Pharmacology and Experimental Therapeutics. 355(3). 397–409. 206 indexed citations

Eddins, Donnie, Terence G. Hamill, Christopher E. Cannon, et al.. (2013). The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey. Psychopharmacology. 231(3). 511–519. 27 indexed citations

Jamieson, Craig, Robert A. Campbell, Iain Cumming, et al.. (2010). A novel series of positive modulators of the AMPA receptor: Discovery and structure based hit-to-lead studies. Bioorganic & Medicinal Chemistry Letters. 20(19). 5753–5756. 33 indexed citations

Jamieson, Craig, John Maclean, Robert A. Campbell, et al.. (2010). Structure based evolution of a novel series of positive modulators of the AMPA receptor. Bioorganic & Medicinal Chemistry Letters. 21(2). 805–811. 24 indexed citations

Jamieson, Craig, Robert A. Campbell, Iain Cumming, et al.. (2010). A novel series of positive modulators of the AMPA receptor: Structure-based lead optimization. Bioorganic & Medicinal Chemistry Letters. 20(20). 6072–6075. 22 indexed citations

Grove, Simon J. A., Craig Jamieson, John Maclean, John A. Morrow, & Zoran Ranković. (2010). Positive Allosteric Modulators of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor. Journal of Medicinal Chemistry. 53(20). 7271–7279. 30 indexed citations

Fitzsimons, Carlos P., John A. Morrow, B.W.M.M. Peeters, et al.. (2009). Antiglucocorticoids, Neurogenesis and Depression. Mini-Reviews in Medicinal Chemistry. 9(2). 249–264. 15 indexed citations

Lutz, E.M., Chris Mackenzie, John A. Morrow, et al.. (2006). Chimaeric VIP2/PACAP Receptors Reveal That Agonist Pharmacology but not Signal Transduction Is Determined by Extracellular Domain 1. Annals of the New York Academy of Sciences. 805(1). 574–578.

10.

Morrow, John A., John Maclean, & Craig Jamieson. (2006). Recent advances in positive allosteric modulators of the AMPA receptor.. PubMed. 9(5). 571–9. 23 indexed citations

11.

Slattery, David A., John A. Morrow, Alan L. Hudson, et al.. (2005). Comparison of Alterations in c-fos and Egr-1 (zif268) Expression Throughout the Rat Brain Following Acute Administration of Different Classes of Antidepressant Compounds. Neuropsychopharmacology. 30(7). 1278–1287. 50 indexed citations

12.

Morrow, John A., et al.. (2003). Therapeutic potential of potassium channel modulators for CNS disorders. Expert Opinion on Therapeutic Patents. 13(1). 23–32. 6 indexed citations

13.

Lutz, E.M., Chris Mackenzie, Mary K. Johnson, et al.. (1999). Domains determining agonist selectivity in chimaeric VIP₂ (VPAC₂)/PACAP (PAC₁) receptors. British Journal of Pharmacology. 128(4). 934–940. 20 indexed citations

14.

Morrow, John A., et al.. (1998). Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome¹. FEBS Letters. 439(3). 334–340. 56 indexed citations

15.

Quinn, John P., et al.. (1994). The rat vasoactive intestinal polypeptide cyclic AMP response element regulates gene transcriptional responses differently in neonatal and adult rat sensory neurons. Neuroscience Letters. 167(1-2). 19–23. 10 indexed citations

16.

Morrow, John A. & Frazer J. Rixon. (1994). Analysis of sequences important for herpes simplex virus type 1 latency-associated transcript promoter activity during lytic infection of tissue culture cells. Journal of General Virology. 75(2). 309–316. 6 indexed citations

17.

Lutz, E.M., W. John Sheward, West Km, et al.. (1993). The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Letters. 334(1). 3–8. 442 indexed citations

18.

Morrow, John A., E.M. Lutz, West Km, George Fink, & Anthony J. Harmar. (1993). Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Letters. 329(1-2). 99–105. 109 indexed citations

19.

Velasco, Carlos, Edwin K. Jackson, John A. Morrow, et al.. (1993). Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion. Cardiovascular Research. 27(1). 121–128. 34 indexed citations

20.

Morrow, John A., R. D. Fell, & L. Bruce Gladden. (1988). Respiratory alkalosis: no effect on blood lactate decline or exercise performance. European Journal of Applied Physiology. 58(1-2). 175–181. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact